Table 3 Haplogroup distribution of North African Jewish (NAF) T2DM patients who developed complications and the "No complications" group as in table 1. Patients included in this table may have more than one complication.
Haplogroup | All NAF n (%) | No complication n (%) | Cardiovascular n (%) | Retino-pathy n (%) | Nephro-pathy n (%) |
|---|---|---|---|---|---|
U (nonK) | 21 (9.4) | 9 (12.3) | 5 (9.8) | 3 (5) | 8 (9.1) |
K | 32 (14.3) | 12 (16.4) | 4 (7.8) | 10 (16.7) | 9 (10.2) |
1HV* | 35 (15.7) | 6 (8.2) | 13 (25.4) | 12 (20) | 19 (21.6) |
H | 72 (32.3) | 20 (27.4) | 20 (39.2) | 22 (36.7) | 30 (34.1) |
J1** | 8 (3.6) | 5 (6.8) | 1 (2) | 0 | 3 (3.4) |
T | 7 (3.1) | 4 (5.5) | 1 (2) | 1 (1.7) | 2 (2.3) |
WXI | 23(10.3) | 9 (12.3) | 4 (7.8) | 4 (6.7) | 8 (9.1) |
2Others | 25 (11.2) | 8 (11) | 3 (5.9) | 8 (13.3) | 9 (10.2) |
Total | 223 | 73 | 51 | 60 | 88 |